Search

Your search keyword '"Basso, Sabrina"' showing total 184 results

Search Constraints

Start Over You searched for: Author "Basso, Sabrina" Remove constraint Author: "Basso, Sabrina"
184 results on '"Basso, Sabrina"'

Search Results

1. A formação inicial para o Ensino de Ciências e a Educação Inclusiva: o currículo das licenciaturas

2. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

3. Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts

4. Clinical Trials of Cellular Therapies in Solid Tumors

6. Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia

7. Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies

8. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

9. Treosulfan Therapeutic Drug Monitoring: Optimizing Conditioning Therapy in Pediatric Hematopoietic Stem Cell Transplantation

12. Long-lasting responses with chemotherapy followed by T-cell therapy in recurrent or metastatic EBV-related nasopharyngeal carcinoma.

13. Successful JC virus-targeted T-cell therapy for progressive multifocal leukoencephalopathy in a lung transplant recipient

14. Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1 mut) for the Treatment of NPM1 mut -Acute Myeloid Leukemia.

15. The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches

16. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

18. Emergence of BCR-ABL–specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term imatinib mesylate treatment

19. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

20. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

21. Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL

22. Post-transplant de novo non donor-specific HLA antibodies are not associated with poor graft outcome in non-sensitized pediatric recipients of kidney transplantation

23. Adoptive Transfer of JC Virus‐Specific T Lymphocytes for the Treatment of Progressive Multifocal Leukoencephalopathy

24. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein–Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient

27. Harnessing T Cells to Control Infections After Allogeneic Hematopoietic Stem Cell Transplantation

28. Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives

29. Air Pollution as a Contributor to the Inflammatory Activity of Multiple Sclerosis

36. Governance of Water Resources Management, through the UGRHI, in the state of São Paulo

38. Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia

39. Infusion of autologous Epstein-Barr virus (EBV)–specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication

40. BCR-ABL–specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors

41. HHV-6 Infection/Reactivation after Allogeneic Stem Cell Transplantation in Pediatric Patients: Epidemiology, Risk Factors and Outcome

42. Failure to removede novodonor-specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody-mediated rejection destined to graft loss - a retrospective study

43. Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts

44. De Novo Donor-Specific HLA Antibodies Developing Early or Late after Transplant Are Associated with the Same Risk of Graft Damage and Loss in Nonsensitized Kidney Recipients

45. Cursos de licenciatura na área de ciências: a temática inclusão escolar de alunos com necessidades educacionais especiais

46. Failure to remove de novo donor‐specific HLA antibodies is influenced by antibody properties and identifies kidney recipients with late antibody‐mediated rejection destined to graft loss – a retrospective study.

48. Immunity to Polyomavirus BK Infection: Immune Monitoring to Regulate the Balance between Risk of BKV Nephropathy and Induction of Alloimmunity

49. Perspectivas críticas na pesquisa sobre formação de professores de ciências

50. Perspectivas críticas na pesquisa sobre formação de professores de ciências

Catalog

Books, media, physical & digital resources